List view / Grid view

News

GBI Research identifies first-in-class as panacea for pharma companies

14 June 2016 | By Mandy Parrett, Editorial Assistant

In the face of the enormous costs involved in bringing a drug to market, pharmaceutical companies are increasingly aiming to develop first-in-class treatments to maximise return on this heavy burden, notes intelligence provider, GBI Research.

Possible new target for psoriasis identified

13 June 2016 | By Victoria White, Digital Content Producer

A small protein in the skin called Rac1 appears to link well-known environmental triggers of the disease with a genetic predisposition to the condition...